38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
1	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely docusate sodium 5 milligram/1 milliliter conventional release ear drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ampicillin 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely flucloxacillin 500 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methyldopa 125 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely norethisterone 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ranitidine bismuth citrate 400 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pentamidine isethionate 300 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely duloxetine (as duloxetine hydrochloride) 60 milligram/1 each gastro-resistant oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dasatinib 70 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sildenafil (as sildenafil citrate) 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ascorbic acid 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sulpiride 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen sodium 275 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely aciclovir 50 milligram/1 gram conventional release cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely magnesium aspartate 2.5 millimole/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pravastatin sodium 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dicycloverine hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely metronidazole 500 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolcapone 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely medroxyprogesterone acetate 400 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trazodone hydrochloride 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 50 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely primidone 50 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ribavirin 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely clodronate disodium 400 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely captopril 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methylcellulose-450 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tranexamic acid 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely etoposide 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium iopodate 500 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cerivastatin sodium 400 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely maraviroc 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolvaptan 15 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nonoxinol 125 milligram/1 gram conventional release vaginal foam	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lacidipine 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenofibrate micronized 67 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mycophenolate mofetil 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely haloperidol 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely acipimox 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lacosamide 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely eletriptan (as eletriptan hydrobromide) 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely medroxyprogesterone acetate 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dofetilide 125 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trimethoprim 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely retigabine 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely indinavir (as indinavir sulfate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely potassium iodate 85 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely indometacin 25 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely theophylline 125 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bumetanide 200 microgram/1 milliliter conventional release oral solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac potassium 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely calcitriol 500 nanogram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely medroxyprogesterone acetate 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely memantine hydrochloride 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely norfloxacin 400 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dehydroepiandrosterone 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely chlorpromazine hydrochloride 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bisacodyl 10 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thioridazine hydrochloride 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter conventional release eye solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely chloramphenicol 5 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tibolone 2.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely eletriptan (as eletriptan hydrobromide) 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phenindione 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cefaclor (as cefaclor monohydrate) 50 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier

Start Previous Page 287 of 342 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442105014	1	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module